Nexcida Therapeutics
About:
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections.
Description:
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections. The company is led by an outstanding team of proven anti-infectives drug developers and is committed to addressing the emerging threat of drug-resistant bacteria. Nexcida Therapeutics was founded in 2014 and is based in Menlo Park, California.
Total Funding Amount:
$2.75M
Headquarters Location:
Menlo Park, California, United States
Founded Date:
2014-01-01
Founders:
Number of Employees:
Last Funding Date:
2015-06-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai